5-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine

Catalog No. :
ACYKDF381
CAS No. :
2223041-06-1
Molecular Formula :
C13H17BF3NO3
Molecular Weight :
303.09

IUPAC Name:5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine

5-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine
IUPAC Name5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine
MDL No.0
Molecular FormulaC13H17BF3NO3
Molecular Weight303.09
SMILESFC(C1=NC=C(OC)C(B2OC(C)(C)C(C)(C)O2)=C1)(F)F
InChI KeyGSYFSNLEFWLEOI-UHFFFAOYSA-N
Synonym5-Methoxy-2-trifluoromethylpyridine-4-boronic acid pinacol ester;5-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)...;5-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine;Pyridine, 5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)-
CAS No.2223041-06-1

Synthetic Route by SureRoute

1. ACYKDF381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYKDF381 route product structure diagram
    ACYKDF3812223041-06-1
Inquiry

2. ACYKDF381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYKDF381 route product structure diagram
    ACYKDF3812223041-06-1
Inquiry

Comments (0)